Literature DB >> 24062968

Adderall-induced Trichotillomania: A Case Report.

Chiranjir Narine1, Sajjad R Sarwar, Theodor B Rais.   

Abstract

Adderall (dextroamphet-amine/amphetamine) is a psychostimulant medication approved by the United States Food and Drug Administration for the treatment of attention deficit hyperactivity disorder. This medication is usually well tolerated with minimal side effects. We report a case of a 12-year-old girl who was prescribed Adderall by her primary care physician to treat her attention deficit hyperactivity disorder and who subsequently developed trichotillomania. A short time following the initiation of the medication, the patient's family members noticed the patient displaying unusual hair-pulling behavior. The patient was referred to a psychiatrist for an evaluation of trichotillomania. Following a thorough evaluation, the decision was made to discontinue the Adderall and switch the patient to guanfacine. The urge to pull her hair along with her anxiety dissipated following this change. Close follow-up was maintained for over a year with both the psychiatrist and the primary care physician, and during this time the patient did not display any unusual hair pulling behaviors. This case appears to display a very unusual side effect of Adderall.

Entities:  

Keywords:  ADHD; Adderall; attention deficit hyperactivity disorder; trichotillomania

Year:  2013        PMID: 24062968      PMCID: PMC3779907     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  7 in total

1.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

2.  Current posttraumatic stress disorder and history of trauma in trichotillomania.

Authors:  Beth S Gershuny; Nancy J Keuthen; Emily L Gentes; Amanda R Russo; Elizabeth C Emmott; Mariko Jameson; Darin D Dougherty; Rebecca Loh; Michael A Jenike
Journal:  J Clin Psychol       Date:  2006-12

3.  Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  R L Findling; E J Short; M J Manos
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-12       Impact factor: 8.829

4.  Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.

Authors:  Tanya E Froehlich; Bruce P Lanphear; Jeffery N Epstein; William J Barbaresi; Slavica K Katusic; Robert S Kahn
Journal:  Arch Pediatr Adolesc Med       Date:  2007-09

5.  How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population-based study.

Authors:  W Barbaresi; S Katusic; R Colligan; A Weaver; V Pankratz; D Mrazek; S Jacobsen
Journal:  Acta Paediatr Suppl       Date:  2004-05

6.  Childhood trichotillomania: clinical phenomenology, comorbidity, and family genetics.

Authors:  R A King; L Scahill; L A Vitulano; M Schwab-Stone; K P Tercyak; M A Riddle
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-11       Impact factor: 8.829

7.  Characteristics of 60 adult chronic hair pullers.

Authors:  G A Christenson; T B Mackenzie; J E Mitchell
Journal:  Am J Psychiatry       Date:  1991-03       Impact factor: 18.112

  7 in total
  1 in total

1.  Severe Trichotillomania: An Unusual Trigger of Recurrent Diabetic Ketoacidosis.

Authors:  Larissa Check; Gabriela Figueroa; Lidice Galindo; Jamie Pham; Robert Sherertz
Journal:  Cureus       Date:  2022-01-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.